Dyne Therapeutics Inc (NASDAQ: DYN) – Suitable For Long Term Buy?
Currently, there are 100.40M common shares owned by the public and among those 74.33M shares have been available to trade. The company’s stock has a 5-day price change of -28.83% and 1.69% over the past three months. DYN shares are trading 140.15% year to date (YTD), with the 12-month market performance up to 180.18% higher. […]
Dyne Therapeutics Inc (DYN): A Great Stock For Handling Current Market Conditions?
Citadel Advisors LLC recently announced the acquisition of new stake in Dyne Therapeutics Inc (NASDAQ:DYN). The institutional investor has increased its shareholding in the Healthcare company by 11.54% to 3.02 million shares with purchase of 0.31 million shares. This fresh investment now brings its stake to 4.92% valued currently at $33.44 million. In addition, BlackRock […]
Following The Money: Institution’s Growing Stake In Dyne Therapeutics Inc (NASDAQ: DYN)
Citadel Advisors LLC has recently announced that it has increased stake in Dyne Therapeutics Inc (NASDAQ:DYN) by 11.54%. After grabbing 3.02 million shares, the institutional investor is now in possession of 0.31 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 4.92% having worth around $33.44 million. Moreover, […]
